Nanoscale chromatin domains regulate gene activity in mammals, indicating new targets for diagnosing and treating diseases.
Nanoscale chromatin domains have emerged as fundamental units of mammalian genome organization during interphase and mitosis. Single-molecule localization microscopy now enables their direct visualization, revealing conserved features including characteristic packing, enrichment of linker histones, and radial stratification of histone marks. These domains act as dynamic regulators of gene activity, remodel in response to developmental and environmental cues, and become disrupted in disease. Experimental findings and biophysical modelling point to internucleosomal interactions and epigenetic reactions as key drivers of their organization. By situating them alongside lamin- and nucleolus-associated domains, we propose a unified biophysical framework for genome organization across scales. Their recurrent disruption in aging and disease makes them compelling targets for diagnosis and intervention.
No takes yet. Share an insight, caveat, or question.
Vinayak et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: